Status:
COMPLETED
Comparison of Two Endoscopic Biopsic Needles for Pancreatic Tumors
Lead Sponsor:
Société Française d'Endoscopie Digestive
Conditions:
Pancreatic Tumor
Puncture
Eligibility:
All Genders
18+ years
Brief Summary
This observational study compared quality of histological sampling of pancreatic EUS-FNB with the 20-gauge Procore® and 22-gauge Acquire® needles. In total, 68 patients were recruited. Histological di...
Detailed Description
Between March and December 2017, 68 EUS-FNB were consecutively performed in our unit for a pancreatic or peripancreatic mass. The choice of the needle depended upon the availability at the time of adm...
Eligibility Criteria
Inclusion
- All consecutive patients ≥18 who were referred for EUS-FNB for solid pancreatic or peripancreatic mass were included
Exclusion
- non-accessible pancreatic mass because of history of Billroth II or Roux-en-Y reconstruction
- coagulation disorders (such as partial thromboplastin time \>42 seconds, prothrombin time \[Quick value\] \<50%, platelet count \<50 000/mm³), treatment with clopidogrel, pregnancy.
- patients \<18 years of age
Key Trial Info
Start Date :
March 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 15 2017
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT03444051
Start Date
March 1 2017
End Date
December 15 2017
Last Update
February 23 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinique PARIS-BERCY
Charenton-le-Pont, France, 94220